← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 28, 2018Last known activity
Sep 4, 2025
Timeline
2010s
- Jun 1, 2015
NextCure, Inc.— Founded
Drugs by trial phase (17 distinct, 10 trials)
Phase 2 (14 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06941857CollaboratorPhase 2Sep 4, 2025
- NCT06792552Lead sponsorPhase 1Feb 26, 2025
- NCT06774963Lead sponsorPhase 1Jan 7, 2025
- NCT05787496Lead sponsorPhase 1Feb 28, 2023
- NCT05787496Study directorPhase 1Feb 28, 2023
- NCT05572684Study directorPhase 1/Phase 2Oct 6, 2022
- NCT05572684Lead sponsorPhase 1/Phase 2Oct 6, 2022
- NCT04875806Lead sponsorPhase 1/Phase 2Jun 30, 2021
- NCT04875806Study directorPhase 1/Phase 2Jun 30, 2021
- NCT04699123CollaboratorPhase 2Feb 4, 2021
- NCT04430933Lead sponsorPhase 1/Phase 2Jul 6, 2020
- NCT04430933Study directorPhase 1/Phase 2Jul 6, 2020
- NCT04408599Lead sponsorPhase 1/Phase 2Jun 10, 2020
- NCT04408599Study directorPhase 1/Phase 2Jun 10, 2020
- NCT03665285Lead sponsorPhase 1/Phase 2Sep 28, 2018
Details
- Founded
- Washington, DC, US Jun 1, 2015
- Last known activity
- Sep 4, 2025